Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.07 CAD
Change Today 0.00 / 0.00%
Volume 187.5K
MOM On Other Exchanges
As of 2:08 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

James F. Kinley C.A.

Chief Financial Officer, Miraculins Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 4 different industries.

As of Fiscal Year 2014


Mr. James F. Kinley, CA serves as the Chief Financial Officer of Marsala Biotech Inc. Mr. Kinley is responsible for the financial operations of Marsala through its contract with Genesys Venture, Inc. Mr. Kinley has been the Chief Financial Officer of Medicure Inc. since September 21, 2011 and Miraculins Inc. since December 23, 2011. Mr. Kinley serves as the Vice President of Finance at Genesys Venture Inc. and is responsible for its financial operations and client companies, ...

Read Full Background

Corporate Headquarters*

6-1250 Waverley Street
Winnipeg, Manitoba R3T 6C6


Phone: 204-453-1408
Fax: 204-453-1546

Board Members Memberships*

There is no Board Members Memberships data available.


Bachelor's Degree
University of Manitoba

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Total Number of Options50,000

Total Compensation*

Total Calculated CompensationC$7,574
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MOM:CN C$0.07 CAD 0.00


Valerie Barber Palmieri Chief Executive Officer and President
Vermillion, Inc.
Mark Christopher Capone Chief Executive Officer and President
Myriad Genetics Inc.
Russell Cummings Chief Executive Officer, Executive Director and Member of Investment Committee
Imperial Innovations Group plc
403.0K GBP
Kevin B. Kowbel Chairman and Interim Chief Executive Officer
Health Discovery Corporation
Jan Groen Ph.D.Chief Executive Officer, President and Executive Director
MDxHealth SA
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIRACULINS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at